Listen to this #pressrelease on #soundcloud about a new #research perspective #published in Volume 15, entitled, 'Combining causal and correlative approaches to discover biomarkers of response to paclitaxel.'

soundcloud.com/oncotarget/com…

#cancer #perspective #audio #podcast #oa

Oncotarget is a promotional partner of the European Association for Cancer Research Conference, 'Cancer Multiomics and Computational Biology,' from April 30–May 2, 2024. eacr.org/conference/can…

Read the latest Oncotarget #announcements and #pressreleases : oncotarget.com/news/pr/ #openaccess #peerreviewed #oncology #cancer #researchpapers

Scientific integrity is a crucial component of scholarly publishing. At Oncotarget, a growing industry of digital technologies, tools and ideas are constantly being added to our robust scientific integrity process: oncotarget.com/scientific_int…

#PaperoftheDay : 'Novel therapeutic bispecific antibodies for B-cell lymphoma targeting IgM and other antigens on the B-cell surface'

DOI: doi.org/10.18632/oncot…

#cancerresearch #oncology #MedEd

Submit a paper online with Oncotarget: oncotarget.msubmit.net/cgi-bin/main.p…

#peerreviewed #journal #openaccess #openscience #publishing #author #research #cancer #oncology #publication

How to contact Oncotarget: oncotarget.com/contact/

#openaccess #openscience #peerreviewed #journalpublication #research #research papers #cancer #oncology #meded #publishing

Visit the Oncotarget archive, containing papers published from 2010-2024: oncotarget.com/archive/

Oncotarget.com is a primarily #oncology -focused, #peerreviewed , #openaccess journal. Papers are #published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

#PaperoftheDay : 'Exploring the role of GHRH antagonist MIA-602 in overcoming Doxorubicin-resistance in acute myeloid leukemia'

DOI:
doi.org/10.18632/oncot…

#cancerresearch #oncology #MedEd

Oncotarget recently #published this #trendingwithimpact research #perspective , entitled, “Combining causal and correlative approaches to discover biomarkers of response to paclitaxel.” Neurosurgery at NM

doi.org/10.18632/oncot…

#glioblastoma #research #oa #oncotargetshort #video

Read the latest Oncotarget #announcements and #pressreleases : oncotarget.com/news/pr/ #openaccess #peerreviewed #oncology #cancer #researchpapers

Oncotarget recently #published this #researchpaper in Volume 15: “Neurotrophic-tyrosine receptor kinase gene fusion in papillary thyroid cancer: A clinicogenomic biobank and record linkage study from Finland.' Bayer AG
doi.org/10.18632/oncot…

#cancer #oa #oncotargetshort #video

Oncotarget's Special Collection on Pancreatic Cancer: oncotarget.com/collections/pa… #pancreaticcancer #cancerresearch

Oncotarget is archived and indexed on: MEDLINE, PubMed, PubMed Central, Scopus, EMBASE, and Dimensions (Digital Science).

#PaperoftheDay : 'From osimertinib to preemptive combinations'

DOI: doi.org/10.18632/oncot…

#cancerresearch #oncology #MedEd

Oncotarget follows the guidelines based on the recommendations of the Committee on Publication Ethics (COPE). Oncotarget complies with the Committee's Code of Conduct and adheres to its Best Practice Guidelines. oncotarget.com/ethics-stateme…

Impact Journals (Oncotarget's publisher) is a supporter and exhibitor of the SSP 46th Annual Meeting from May 29 - 31, 2024, in Boston, MA. customer.sspnet.org/SSP/ssp/AM24/H…

Listen on #Soundcloud to a #pressrelease about the #researchpaper , 'Neurotrophic-tyrosine receptor kinase gene fusion in papillary thyroid cancer: A clinicogenomic biobank and record linkage study from Finland.'
soundcloud.com/oncotarget/ntr…

#cancer #finland #thyroidcancer #audio #oa

On March 15, 2024, Dr. Blagosklonny from Roswell Park Comprehensive Cancer Center published a research perspective in Oncotarget's Volume 15, entitled, “From osimertinib to preemptive combinations” doi.org/10.18632/oncot…